Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 4/20 | 0.62 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.50 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.49 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.49 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DPYD | Q12882 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL468924 | 1.00 | CHAT (0.62) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL16105737 | 1.00 | CHAT (0.62) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL318156 | 0.94 | CHAT (0.54) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL318157 | 0.94 | CHAT (0.54) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL29673987 | 0.94 | CHAT (0.54) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL3314625 | 0.89 | CHAT (0.47) | CHATNFE2L2PTGER4PTGER3PTGER2 | |
| SCHEMBL6546259 | 0.89 | CHAT (0.47) | CHATNFE2L2PTGER4PTGER3PTGER2 | |
| SCHEMBL3314632 | 0.85 | CHAT (0.51) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL6546307 | 0.85 | CHAT (0.51) | CHATNFE2L2TRPA1PTGER4PTGER3 | |
| SCHEMBL6546138 | 0.85 | CHAT (0.51) | CHATNFE2L2TRPA1PTGER4PTGER3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120172340-A1 | Compositions and Methods for Selectively Activating Human Sirtuins | BIOMOL INTERNATIONAL L.P. (US) | 2012-07-05 | — | — | US | claimed |
| US-10358540-B2 | Process and system for reducing volatile compound emissions from a product | GM Global Technology Operations LLC (US) | 2019-07-23 | — | — | US | disclosed |
| US-20180355141-A1 | PROCESS AND SYSTEM FOR REDUCING VOLATILE COMPOUND EMISSIONS FROM A PRODUCT | GM Global Technology Operations LLC | 2018-12-13 | — | — | US | disclosed |
| US-9419307-B2 | Organic electrolyte and organic electrolyte storage battery | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2016-08-16 | — | — | US | disclosed |
| US-20150004484-A1 | ORGANIC ELECTROLYTE AND ORGANIC ELECTROLYTE STORAGE BATTERY | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2015-01-01 | — | — | US | disclosed |
| US-20140370375-A1 | ORGANIC ELECTROLYTE AND ORGANIC ELECTROLYTE STORAGE BATTERY | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-12-18 | — | — | US | disclosed |
| EP-2797153-A1 | ORGANIC ELECTROLYTE, AND ORGANIC ELECTROLYTE STORAGE BATTERY | JX Nippon Oil & Energy Corporation (JP) | 2014-10-29 | — | — | EP | disclosed |
| EP-2797154-A1 | ORGANIC ELECTROLYTE, AND ORGANIC ELECTROLYTE STORAGE BATTERY | JX Nippon Oil & Energy Corporation (JP) | 2014-10-29 | — | — | EP | disclosed |
| US-20140302387-A1 | ORGANIC ELECTROLYTE AND ORGANIC ELECTROLYTE STORAGE BATTERY | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-10-09 | — | — | US | disclosed |
| EP-2784868-A1 | ORGANIC ELECTROLYTE AND ORGANIC ELECTROLYTE STORAGE BATTERY | JX Nippon Oil & Energy Corporation (JP) | 2014-10-01 | — | — | EP | disclosed |
| CN-103391777-A | Sirtuin modulators as virus production modulators | UNIV PRINCETON | 2013-11-13 | — | — | CN | disclosed |
| US-20120172340-A1 | Compositions and Methods for Selectively Activating Human Sirtuins | BIOMOL INTERNATIONAL L.P. (US) | 2012-07-05 | — | — | US | disclosed |
| WO-2005058917-A2 | NEW OXAZOLINE LIGANDS FOR ASYMMETRIC CATALYSIS | THE PENN STATE RESEARCH FOUNDATION (US) | 2005-06-30 | — | — | WO | disclosed |
| US-6791260-B2 | Organic electroluminescent element, panel and apparatus using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2004-09-14 | — | — | US | disclosed |
| EP-0717098-B1 | A refrigerating machine oil and a fluid composition for use in a refrigerating machine | NIPPON MITSUBISHI OIL CORP (JP) | 2004-01-21 | — | — | EP | disclosed |
| US-20030117070-A1 | Organic electroluminescent element, panel and apparatus using the same | JOLED INC (JP) | 2003-06-26 | — | — | US | disclosed |
| US-5817251-A | AROMATIC HYDROCARBON LUBRICANT | NIPPON OIL CO., LTD. (JP) | 1998-10-06 | — | — | US | disclosed |
| US-5711895-A | Fluid composition for use in a refrigerating machine in which the refrigerating machine oil is at least one hydrocarbon compound of a formula consisting of two phenyl groups joined through an alkylene or alkenylene group | NIPPON OIL CO., LTD. (JP) | 1998-01-27 | — | — | US | disclosed |
| EP-0717098-A2 | A refrigerating machine oil and a fluid composition for use in a refrigerating machine | NIPPON OIL CO. LTD. (JP) | 1996-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172340-A1 | Compositions and Methods for Selectively Activating Human Sirtuins | SIRT1, SIRT7, SIRT5 | CHAT 579/4885NFE2L2 2187/4885TRPA1 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.